Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Adventrx reports CoFactor phase IIb overall survival results

June 18, 2008

Oncothyreon initiates phase I PX-866 trial in patients with solid tumors

June 18, 2008

JX-594 well tolerated, active in refractory primary and metastatic liver cancer

June 18, 2008

Exelixis and FDA agree on Special Protocol Assessment for XL-184 phase III trial

June 18, 2008

New phase I and II data on BIBW-2992 reported

June 18, 2008

CBP-501 well tolerated alone and with cisplatin in phase I solid tumor studies

June 18, 2008

LLS and Aegera to initiate phase I/II trial of targeted blood cancer therapy AEG-35156

June 17, 2008

Phase I studies characterize MK-0646 in solid tumor patients

June 17, 2008

Z-360 safe when combined with gemcitabine in pancreatic cancer patients

June 17, 2008

Chemokine reports final results of CTCE-9908 phase I/II trial in cancer

June 16, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...